VHPB Centre for Evaluation of Vaccination (CEV) |
Executive Secretary Administrative and Scientific Secretariat |
privacy statement
|
Rotterdam, The Netherlands, November 13-14, 2008
Thursday, November 13, 2008
Session 1 Opening and objectives
Chair: S.W. Schalm, P. van Damme
Session 2 The health care system in The Netherlands
Chair: S. Schalm, J. Ward
09.45 – 10.05
National immunisation program and viral hepatitis immunisation policies 1Mb (.pdf)
H. Houweling
10.05 – 10.25
National program and epidemiology of Hepatitis C 280Kb (.pdf)
H. Reesink
10.40 – 10.55 Coffee Break
Session 3 Surveillance systems in The Netherlands
Chair: J. Van Steenbergen , P. Bonanni
10.55 – 11.15
Overview of HAV, HBV, and HCV surveillance 389Kb (.pdf)
S. Hahné
11.15 – 11.35
Mortality due to chronic viral hepatitis 383Kb (.pdf)
S.W. Schalm
11.35 – 11.55
Need for chronic viral hepatitis monitoring system 1.1Mb (.pdf)
H.L.A. Janssen
12.10 – 13.40Lunch
Session 4 Epidemiology of viral hepatitis in The Netherlands
Chair: H. Zaaijer, A Zanetti
13.40 – 14.00
Epidemiology of hepatitis B in The Netherlands 848Kb (.pdf)
M.Kretzschmar
14.00 – 14.20
Epidemiology of hepatitis C in The Netherlands 384Kb (.pdf)
S. Slavenburg
14.20 –14.40
Molecular epidemiology of HCV infection in The Netherlands 531Kb (.pdf)
T. van de Laar
14.40 – 15.00
Molecular epidemiology of HBV infection in The Netherlands 375Kb
H. Boot
15.00 – 15.15 Discussion
15.15 – 15.35 Coffee break
15.35 – 15.55
Epidemiology of hepatitis A and E in The Netherlands 1Mb(.pdf)
J. Van Steenbergen
15.55 – 16.15
Migration and viral hepatitis 686Kb (.pdf)
T. Wörmann
16.15 – 16.30 Discussion
Session 5 Prevention and control of viral hepatitis in The Netherlands
Chair: H. Zaaijer, A. Zanetti
16.30 – 16.50
Limited control of hepatitis A by decentralized vaccination strategies. 234 Kb (.pdf)
J. van Steenbergen
16.50 – 17.10
Approach to the different risk groups for HBV and/or HCVR. 478Kb (.pdf)
R. de Knegt
17.10 – 17.30
Screening of migrants. 400Kb (.pdf)
I. Veldhuijzen
17.50 – 18.00 Summary by the chairs and Close of the day
Friday, November 14, 2008
Session 6 Prevention and control of viral hepatitis in The Netherlands
Chair: C.A.B. Boucher, F. Roudot-Thoraval
09.00 – 09.20
Viral hepatitis coinfection in HIV-infected patients.
A.Hoepelman
09.20 – 09.40
Influence of treatment on control of chronic viral hepatitis
B.J.H. Richardus
09.40 – 10.00
Health care-associated viral hepatitis 275Kb (.pdf)
H. Zaaijer
10.00 – 10.20
Pregnancy and viral hepatitis 339Kb (.pdf)
G.J. Boland
10.20 – 10.40 Discussion and lessons learnt
10.40 – 11.00 Coffee break
Session 7 Vaccination programmes
Chair: N. Emiroglu, A. C. M. Kroes
11.00 – 11.20
Update on prevention and control of hepatitis B in the WHO European Region. 510Kb (.pdf)
N. Emiroglu
11.20 – 11.40
Hepatitis B vaccination in The Netherlands: Risk group approach 450Kb (.pdf)
S. Hahné
11.40 – 12.00
Hepatitis B vaccination in The Netherlands: Universal approach 475Kb (.pdf)
C. Richter
12.30 – 14.00 Lunch
Session 8 Conclusions of the meeting
Chair: J. Hallauer, S Wiersma
14.00 – 15.00
Presentation of the VHPB meeting conclusions143Kb (.pdf)
D. FitzSimons
15.00 Close of the meeting